Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.
William W KempDaniel I Clayton-ChubbAmmar MajeedKristen M GlenisterDianna J MaglianoJohn LubelLisa BourkeDavid SimmonsStuart Keith RobertsPublished in: Journal of gastroenterology and hepatology (2021)
Metabolic-associated fatty liver disease is a highly prevalent condition within this large community cohort. Application of the MAFLD definition increased prevalence of fatty liver disease by including people with dual etiologies of liver disease.
Keyphrases